Cargando…

Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge

We previously generated a panel of human monoclonal antibodies (mAbs) against Zika virus (ZIKV) and identified one, ZIKV-116, that shares germline usage with mAbs identified in multiple donors. Here we show that ZIKV-116 interferes with ZIKV infection at a post-cellular attachment step by blocking v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Haiyan, Xu, Lily, Bombardi, Robin, Nargi, Rachel, Deng, Zengqin, Errico, John M., Nelson, Christopher A., Dowd, Kimberly A., Pierson, Theodore C., Crowe, James E., Diamond, Michael S., Fremont, Daved H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041715/ https://www.ncbi.nlm.nih.gov/pubmed/31757867 http://dx.doi.org/10.1084/jem.20191792

Ejemplares similares

Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect against Spondweni Virus Infection and Pathogenesis in Mice
por: Salazar, Vanessa, et al.
Publicado: (2019)

Potent Dengue Virus Neutralization by a Therapeutic Antibody with Low Monovalent Affinity Requires Bivalent Engagement
por: Edeling, Melissa A., et al.
Publicado: (2014)

Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2019)

Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope
por: Austin, S. Kyle, et al.
Publicado: (2012)

Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses
por: Tai, Wanbo, et al.
Publicado: (2018)

Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2020)

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
por: VanBlargan, Laura, et al.
Publicado: (2021)

Structural basis of West Nile virus neutralization by a therapeutic antibody
por: Nybakken, Grant E., et al.
Publicado: (2005)

Genotypic Differences in Dengue Virus Neutralization Are Explained by a Single Amino Acid Mutation That Modulates Virus Breathing
por: Dowd, Kimberly A., et al.
Publicado: (2015)

Physics of electron cyclotron current drive on DIII-D
por: Petty, C C, et al.
Publicado: (2002)

The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
por: Shrestha, Bimmi, et al.
Publicado: (2010)

A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy
por: Hassan, Ahmed O., et al.
Publicado: (2019)

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
por: VanBlargan, Laura A., et al.
Publicado: (2022)

The mechanistic basis of protection by non-neutralizing anti-alphavirus antibodies
por: Earnest, James T., et al.
Publicado: (2021)

Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
por: Dussupt, Vincent, et al.
Publicado: (2020)

Regulation of Na(+) channel inactivation by the DIII and DIV voltage-sensing domains
por: Hsu, Eric J., et al.
Publicado: (2017)

A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes
por: Thompson, Bruce S., et al.
Publicado: (2009)

Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses
por: VanBlargan, Laura A., et al.
Publicado: (2021)

The Type-Specific Neutralizing Antibody Response Elicited by a Dengue Vaccine Candidate Is Focused on Two Amino Acids of the Envelope Protein
por: VanBlargan, Laura A., et al.
Publicado: (2013)

Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus
por: Doyle, Michael P., et al.
Publicado: (2022)

2904. Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice
por: Jagger, Brett W, et al.
Publicado: (2019)

Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity
por: Earnest, James T., et al.
Publicado: (2019)

Observation of suprathermal electrons during magnetic reconnection at the sawtooth instability in DIII-D TOKAMAK
por: Savrukhin, R V, et al.
Publicado: (2002)

Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy
por: Wessel, Alex W., et al.
Publicado: (2020)

Augmented Zika and Dengue Neutralizing Antibodies Are Associated With Guillain-Barré Syndrome
por: Lynch, Rebecca M, et al.
Publicado: (2019)

Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice
por: Dunn, Matthew D, et al.
Publicado: (2010)

Antibody-mediated immunity to SARS-CoV-2 spike
por: Errico, John M., et al.
Publicado: (2022)

Zeeman-Field-Tuned Topological Phase Transitions in a Two-Dimensional Class-DIII Superconductor
por: Deng, W. Y., et al.
Publicado: (2016)

Josephson effects in the junction formed by DIII-class topological and s-wave superconductors with an embedded quantum dot
por: Gao, Zhen, et al.
Publicado: (2016)

A VSV-based Zika virus vaccine protects mice from lethal challenge
por: Emanuel, Jackson, et al.
Publicado: (2018)

Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD
por: Errico, John M., et al.
Publicado: (2021)

Zika Virus Is Not Uniquely Stable at Physiological Temperatures Compared to Other Flaviviruses
por: Goo, Leslie, et al.
Publicado: (2016)

A molecular understanding of alphavirus entry
por: Holmes, Autumn C., et al.
Publicado: (2020)

Replication in the presence of dengue convalescent serum impacts Zika virus neutralization sensitivity and fitness
por: Marano, Jeffrey M., et al.
Publicado: (2023)

Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
por: Liu, Zhuoming, et al.
Publicado: (2021)

Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus
por: Pal, Pankaj, et al.
Publicado: (2013)

Human T cell responses to Dengue and Zika virus infection compared to Dengue/Zika coinfection
por: Badolato‐Corrêa, Jessica, et al.
Publicado: (2017)

Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection
por: Collins, Matthew H., et al.
Publicado: (2017)

Reporter Virus Neutralization Test Evaluation for Dengue and Zika Virus Diagnosis in Flavivirus Endemic Area
por: Nunes, Jannyce G. C., et al.
Publicado: (2021)

Immunogenicity of a West Nile Virus DIII-Cholera Toxin A(2)/B Chimera after Intranasal Delivery
por: Tinker, Juliette K., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3eq2oimggic0q97ucbvfjsvbr2